(lp0
S"Better Buy: Pfizer Inc. vs. Merck &amp; Co. Inc. Motley Fool - Feb 21, 2017 Investors have really liked Merck  stock over the last 12 months, with shares jumping around 30%. Pfizer  has performed pretty well also, but not nearly at the level of Merck. The big drugmaker's stock is up close to 15%. But past&nbsp;...Merck &amp; Co., Inc.  Files An 8-K Material Impairments - Market ExclusiveMerck &amp; Co., Inc.  Fell -0.29% - TopChronicle"
p1
aS"EOD Risers: McDonald's Corporation, Merck &amp; Co., Inc., Microsoft Corporation ... DirectorsTalk Interviews - Mar 16, 2017 The stock price for Merck &amp; Co., Inc. found using EPIC:  a global healthcare company, climbed 0.78% or 0.5 points during the course of yesterday's session."
p2
aS"EOD Risers: JPMorgan Chase &amp; Co., McDonald's Corporation, Merck &amp; Co., Inc ... DirectorsTalk Interviews - Mar 15, 2017 Shares in JPMorgan Chase &amp; Co. ticker lookup code:  a financial holding company engaged in investment banking, financial services, increased 0.16% or 0.15 points during the course of yesterday's session."
p3
aS'Upcoming Earnings Results: Merck &amp; Co., Inc.  Normangee Star - 4 hours ago Now the company Insiders own 0.05% of Merck &amp; Company, Inc. shares according to the proxy statements. Finally, Mascoma Wealth Management LLC bought a new position in shares of Merck &amp; Co.Landmark Financial Advisors LLC Holds Position in Merck &amp; Co., Inc.  - BNB Daily O Shaughnessy Asset Management LLC Reduces Position in Merck &amp; Co., Inc.  - Sports Perspectives'
p4
aS"Merck: Total Return Play With Slow Growth... Hold Seeking Alpha - Mar 3, 2017 This article is about Merck  and why it's a hold investment. MRK has in the last 50 months had an above average total return."
p5
aS"EOD Risers: Merck &amp; Co., Inc., Microsoft Corporation, Nike Inc, Pfizer Inc. DirectorsTalk Interviews - Mar 2, 2017 The share price for Merck &amp; Co., Inc. company symbol:  a global healthcare company, gained 0.52% or 0.34 points during the course of yesterday's session."
p6
aS"Technicals in Focus for Merck &amp; Co., Inc.  The USA Commerce - 20 hours ago We have gathered the technical data on Merck &amp; Co., Inc. , and see some interesting trends in the stock's behavior of late."
p7
aS"EOD Risers: Merck &amp; Co., Inc., Microsoft Corporation, Pfizer Inc. DirectorsTalk Interviews - Mar 6, 2017 Shares in Merck &amp; Co., Inc. with ticker code:  a global healthcare company, moved up 0.76% or 0.5 points in Friday's trading session."
p8
aS"FDA OKs expanded use of Merck's Keytruda Seeking Alpha - Mar 15, 2017 The FDA approves the use of Merck's  PD-1 inhibitor KEYTRUDA  to treat adult and pediatric patients with refractory classical Hodgkin lymphoma or who have relapsed after three or more prior lines of therapy."
p9
aS'Merck Is A Great Healthcare Pick, But Overvalued At This Time Seeking Alpha - Mar 13, 2017 On February 2, Merck &amp; Co Inc.  reported their Q4 results, with an EPS of $0.89 in-line with estimates and revenue of $10.12 billion missing estimates by $100 million.'
p10
a.